Oceanía · Actualidad general · The Mercury

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Publicado por The Mercury · Australia hace 8 h

Recce Pharmaceuticals has signed an exclusive licensing and commercialisation agreement with Arrotex Pharmaceuticals for its RECCE 327 (R327G) topical gel to treat diabetic foot…

Leer el artículo completo en The Mercury Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.themercury.com.au)

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

También te puede interesar

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Wild moment tradies tackle, zip-tie masked axeman after alleged carjacking attempt on Melbourne road

AVer Announces FONE700+ Scalable Ceiling Speakerphone System for Large Hybrid Meeting Spaces

On pollies and why we should maintain the rage but with better behaviour and smarter outcomes

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Compartir

También te puede interesar

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Wild moment tradies tackle, zip-tie masked axeman after alleged carjacking attempt on Melbourne road

AVer Announces FONE700+ Scalable Ceiling Speakerphone System for Large Hybrid Meeting Spaces

On pollies and why we should maintain the rage but with better behaviour and smarter outcomes